Emeis Stock Falls Below Its Moving Average and Approaches a Technical Support
The healthcare services group's stock is down mid-session, contrary to the upward trend of the SBF 120. The movement occurs in a Parisian market caught between the easing of the VIX and ongoing geopolitical tensions in the Middle East. Despite this decline, the stock maintains a comfortable lead over the year.
2.5% Decline in Session Despite a Well-Oriented SBF 120
Emeis falls 2.5% to €14.41 mid-session, while the SBF 120 gains 0.56%. The stock is at the bottom of the broader index, going against the day's strongest gains (STMicroelectronics, Atos, Worldline). The decline erases part of the stock's weekly gain, now at -4.51% over seven days. Over three months, the performance is negative at -6.31%, but the stock is still up 41.41% over the year.
Stock Falls Below the 20-Day Moving Average but Maintains a Cushion Over the 200-Day Moving Average
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
At €14.41, the price falls below its 20-day moving average (€14.90) by 3.29%. However, it remains above the 50-day moving average at €14.20 and the 200-day moving average at €13.86, maintaining a technical cushion of about 4% on the latter. The RSI at 51 indicates a lack of strong directional signals, while the MACD slightly slips below its signal line. The identified support at €13.71 is just over 4% below the current price and coincides with the 200-day moving average zone, now closely watched after breaking the 20-day moving average. For reference, the group had confirmed on May 7 a 6.3% organic growth for Q1 2026 and maintained its guidance for an EBITDAR increase of more than 10% for the year.
SectorServices et infrastructure de santé›Etablissements de santé / EHPAD
Free · every morning · before 9am
Never miss a move on your stocks
The trend behind the prices · Euronext
✓ You're in! Check your spam folder.
An error occurred.
Context
Period
Period: S1 2026
Key reported figures
Revenue: 3 011 millions d'euros
Quarterly revenue: 3 011 millions d'euros
EBITDA: 461 millions d'euros
EBITDA margin: 15,3 %
Net income: -40,4 millions d'euros
Free cash flow: -153 millions d'euros
3 862 millions d'euros
Guidance from the release
First-half performance allows for an upward revision of the 2026 guidance; the trend since the start of the year confirms the continued momentum observed in 2025 and even shows performance that exceeded the Group's initial expectations
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
